Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P92
Near historical high
vs 2Y Ago
247.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.21% |
| Q3 2025 | -16.69% |
| Q2 2025 | 34.96% |
| Q1 2025 | -41.47% |
| Q4 2024 | -24.29% |
| Q3 2024 | 40.09% |
| Q2 2024 | 19.50% |
| Q1 2024 | -45.62% |
| Q4 2023 | 0.13% |
| Q3 2023 | 10.50% |
| Q2 2023 | 5.87% |
| Q1 2023 | -28.51% |
| Q4 2022 | -22.03% |
| Q3 2022 | 18.02% |
| Q2 2022 | -5.19% |
| Q1 2022 | -37.05% |
| Q4 2021 | 6.66% |
| Q3 2021 | -6.82% |
| Q2 2021 | 13.44% |
| Q1 2021 | 0.48% |
| Q4 2020 | -54.74% |
| Q3 2020 | -10.59% |
| Q2 2020 | 43.89% |
| Q1 2020 | -21.31% |
| Q4 2019 | -27.59% |
| Q3 2019 | -24.82% |
| Q2 2019 | -16.17% |
| Q1 2019 | 7.79% |
| Q4 2018 | -12.97% |
| Q3 2018 | -16.74% |
| Q2 2018 | -34.03% |
| Q1 2018 | 14.86% |
| Q4 2017 | 2.25% |
| Q3 2017 | -22.58% |
| Q2 2017 | 6.95% |
| Q1 2017 | -54.64% |
| Q4 2016 | 0.41% |
| Q3 2016 | -225.75% |
| Q2 2016 | 17.66% |
| Q1 2016 | 30.81% |